This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Comparing Acthar Gel and Cortrophin in treating Multiple Sclerosis
Ticker(s): MNKWho's the expert?
Institution: University of Wisconsin
- Director, Division of MS/Neuro-Immunology at the Medical College of Wisconsin.
- Currently manages 900 patients with MS.
- Principal Investigator on study investigating the basic mechanisms of multiple sclerosis and has published over 175 abstracts and papers on the use of ingested type I interferons in humans and animal models of autoimmune disease.
Interview GoalDiscussing decision making process regarding cortrophin use vis-à-vis Acthar gel, pricing considerations, and if there is a need for additional data
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
